(S)-N-(1-(3-(Dimethylamino)-1-phenylpropyl)-1H-pyrazol-4-yl)-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide

ID: ALA3298371

Cas Number: 1557232-32-2

PubChem CID: 74983355

Max Phase: Preclinical

Molecular Formula: C24H32N6O

Molecular Weight: 420.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1

Standard InChI:  InChI=1S/C24H32N6O/c1-24(2)12-10-19-20(14-24)27-28-22(19)23(31)26-18-15-25-30(16-18)21(11-13-29(3)4)17-8-6-5-7-9-17/h5-9,15-16,21H,10-14H2,1-4H3,(H,26,31)(H,27,28)/t21-/m0/s1

Standard InChI Key:  XFYUTGIEFKGWND-NRFANRHFSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    9.9697   -9.8033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1851   -9.5484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1851   -8.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9697   -8.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3053   -7.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1258   -7.6285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6056   -8.2909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2751   -9.0497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4547   -9.1359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5177   -8.2385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6039   -7.4180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7640   -8.5740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2947   -8.7573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1889   -7.7076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8270   -7.6766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3119   -7.0092    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0966   -7.2641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0966   -8.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3119   -8.3440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0020   -7.6766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5895   -6.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7645   -6.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5895   -8.3911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0020   -9.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5895   -9.8200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7645   -9.8200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520   -9.1055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7645   -8.3911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520   -6.2477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5270   -6.2477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7645   -5.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
 10 11  2  0
 10 12  1  0
  3 10  1  0
  7 13  1  0
  7 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 15 19  1  0
 20 21  1  6
 21 22  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 23 28  2  0
 20 23  1  0
 29 30  1  0
 29 31  1  0
 22 29  1  0
 15 20  1  0
 12 18  1  0
M  END

Associated Targets(Human)

CLK2 Tchem Dual specificity protein kinase CLK2 (3942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK3 Tclin NT-3 growth factor receptor (2338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.56Molecular Weight (Monoisotopic): 420.2638AlogP: 3.91#Rotatable Bonds: 7
Polar Surface Area: 78.84Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.14CX Basic pKa: 9.65CX LogP: 3.85CX LogD: 1.62
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.61Np Likeness Score: -1.35

References

1. Burch JD, Lau K, Barker JJ, Brookfield F, Chen Y, Chen Y, Eigenbrot C, Ellebrandt C, Ismaili MH, Johnson A, Kordt D, MacKinnon CH, McEwan PA, Ortwine DF, Stein DB, Wang X, Winkler D, Yuen PW, Zhang Y, Zarrin AA, Pei Z..  (2014)  Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.,  57  (13): [PMID:24918870] [10.1021/jm500550e]
2. Burch JD, Barrett K, Chen Y, DeVoss J, Eigenbrot C, Goldsmith R, Ismaili MH, Lau K, Lin Z, Ortwine DF, Zarrin AA, McEwan PA, Barker JJ, Ellebrandt C, Kordt D, Stein DB, Wang X, Chen Y, Hu B, Xu X, Yuen PW, Zhang Y, Pei Z..  (2015)  Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo.,  58  (9): [PMID:25844760] [10.1021/jm501998m]

Source